Agile Therapeutics, Inc. Shareholders' Equity
Agile Therapeutics, Inc. had Shareholders' Equity of -$21.91 million as of 2024-06-30, per its 10-Q filed 2024-08-12.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2024-08-12
- 2024-06-30: Stockholders' Equity Attributable to Parent -$21.91M.
- 2024-03-31: Stockholders' Equity Attributable to Parent -$10.32M.
- 2023-12-31: Stockholders' Equity Attributable to Parent -$16.32M.
- 2023-09-30: Stockholders' Equity Attributable to Parent -$12.41M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2024-06-30 | -$21.91M 10-Q · filed 2024-08-12 | |
| 2024-03-31 | -$10.32M 10-Q · filed 2024-08-12 | |
| 2023-12-31 | -$16.32M 10-Q · filed 2024-08-12 | |
| 2023-09-30 | -$12.41M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | -$12.12M 10-Q · filed 2024-08-12 | |
| 2023-03-31 | -$9.43M 10-Q · filed 2024-08-12 | -$9.43M 10-Q · filed 2023-05-11 |
| 2022-12-31 | -$5.54M 10-Q · filed 2024-08-12 | |
| 2022-09-30 | -$3.02M 10-Q · filed 2023-11-09 | $6.26M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $2.37M 10-Q · filed 2023-11-09 | $3.42M 10-Q · filed 2022-08-11 |
| 2022-03-31 | -$5.36M 10-Q · filed 2023-11-09 | $2.74M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $3.92M 10-K · filed 2024-03-28 | $9.27M 10-K · filed 2022-03-30 |
| 2021-09-30 | $10.68M 10-Q · filed 2022-11-07 | |
| 2021-06-30 | $24.61M 10-Q · filed 2022-11-07 | |
| 2021-03-31 | $35.05M 10-Q · filed 2022-11-07 | |
| 2020-12-31 | $49.33M 10-K · filed 2024-03-28 | |
| 2020-09-30 | $66.13M 10-Q/A · filed 2021-12-30 | |
| 2020-06-30 | $80.80M 10-Q/A · filed 2021-12-30 | |
| 2020-03-31 | $90.61M 10-Q/A · filed 2021-12-30 | |
| 2019-12-31 | $45.74M 10-K · filed 2023-03-23 | |
| 2019-09-30 | $31.90M 10-Q · filed 2019-10-28 | |
| 2019-06-30 | $23.06M 10-Q · filed 2019-10-28 | |
| 2019-03-31 | $24.66M 10-Q · filed 2020-05-05 | |
| 2018-12-31 | $20.17M 10-K · filed 2022-03-30 | |
| 2018-09-30 | $23.18M 10-Q · filed 2019-10-28 | |
| 2018-06-30 | $26.25M 10-Q · filed 2019-10-28 | $26.25M 10-Q · filed 2018-08-03 |
| 2018-03-31 | $30.61M 10-Q · filed 2019-10-28 | |
| 2017-12-31 | $36.32M 10-K · filed 2021-03-01 | |
| 2017-09-30 | $41.56M 10-Q · filed 2017-11-06 | |
| 2017-06-30 | $29.14M 10-Q · filed 2017-07-28 | |
| 2017-03-31 | $35.61M 10-Q · filed 2017-05-08 | |
| 2016-12-31 | $42.29M 10-K · filed 2020-02-20 | |
| 2016-09-30 | $46.67M 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $53.52M 10-Q · filed 2016-08-08 | |
| 2016-03-31 | $60.98M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $29.74M 10-K · filed 2019-03-12 | |
| 2015-09-30 | $32.75M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $41.18M 10-Q · filed 2015-08-13 | |
| 2015-03-31 | $48.76M 10-Q · filed 2015-05-12 | |
| 2014-12-31 | $36.01M 10-K · filed 2018-03-12 | $36.01M 10-K · filed 2015-03-26 |
| 2014-09-30 | $42.38M 10-Q · filed 2014-11-13 | |
| 2014-06-30 | $48.35M 10-Q · filed 2014-08-14 | |
| 2013-12-31 | -$71.44M 10-K · filed 2017-03-15 | -$71.44M 10-Q · filed 2014-08-14 |
| 2012-12-31 | -$58.61M 10-K · filed 2016-03-09 | -$58.61M 10-K · filed 2015-03-26 |
| 2011-12-31 | -$36.01M 10-K · filed 2015-03-26 |